Humaid Al-Shamsi, CEO of Burjeel Cancer Institute and Chairman of Nexomic, shared on LinkedIn:
“Proud to pioneer bone marrow transplantation for selected solid tumors, including germ cell tumors, advanced gestational trophoblastic tumors, and selected Ewing/AYA sarcomas.
Proud of our team and of being a referral center for patients with complex, advanced cancers where treatment options may be limited.
Proud of our Burjeel Cancer Institute / BCI , the most comprehensive and largest cancer network in the UAE.”
Other articles from Humaid Al-Shamsi on OncoDaily.